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Sllml'l'lary 
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system with 
presumed autoimmune etiology. A recent study has suggested the presence of a restricted T 
cell  receptor  (TCR)  V,~ repertoire in  MS  lesions.  The presence of such a  restricted  TCR 
repertoire at the site of inflammation would have important consequences for the pathogenesis 
and the ultimate treatment of MS. To further characterize  the TCR V,~ and Vo repertoire in 
MS plaque tissue, we examined a series of 26 histologically well-characterized  central nervous 
system (CNS) tissue specimens from six MS patients as well as samples from five normal postmortem 
cases and a case of subacute sclerosing panencephalitis.  RNA was extracted from frozen sections 
and cDNAs were amplified by polymerase chain reaction using primers for TCR V,~ (V,~1-18) 
and V0 (Vt~1-19) gene families. This analysis demonstrated a broad TCR V,~-Vo repertoire in 
active lesions, while fewer TCR V genes were detected in chronic plaques and control samples. 
Even though a large number of TCR V~ and Vt~ gene segments were present in the majority 
of active lesions, there were clear differences in the TCR repertoire between plaques from the 
same case, suggesting that local events influence the TCR repertoire at the level ofT cell recruitment 
or T cell expansion. Examination of cytokine mRNAs demonstrated that IL-1 mRNA was present 
in the majority of acute and subacute plaques, while IL-2 and IL-4 mRNA were detected in only 
a few acute lesions. These data demonstrate that the TCIk repertoire in MS plaques is polyclonal. 
However, autoreactive oe/~/T cells thought to be critical in the initiation of the inflammatory 
process probably represent a minor fraction of T cells in active MS plaques and may use a limited 
number of TCR V gene segments for recognition of the autoantigen. 
M 
ultiple sclerosis (MS) 1 is a chronic inflammatory dis- 
ease of central nervous system (CNS) myelin. Early 
MS lesions are characterized by the focal accumulation of ac- 
tivated T cells around small venules (1-5). Later, there is my- 
elin degeneration associated with marked perivenular inflam- 
mation consisting of T  cells, B cells, and macrophages. T 
cells can also be found at the leading edge of plaques and 
in the surrounding normal-appearing white matter (1-5). Since 
myelin is important for saltatory excitation along axons, demy- 
elination leads to loss of neurologic function (1). 
Clonally expanded T  cell populations using a restricted 
set of TCR gene segments may be important in the patho- 
genesis of MS and human autoimmune diseases. An analysis 
of the TCR V,~-V0 repertoire in a MS brain may allow such 
1 Abbreviations used in  this paper: CNS,  central  nervous  system;  MS, 
multiple  sclerosis; SSPE, subacute sclerosing panencephalitis. 
expanded T cell populations to be studied in the target organ 
of the disease. A recent study has suggested that a restricted 
TCR V,~ repertoire is present in MS plaque tissue (6).  To 
further examine the TCR repertoire in MS plaques, we asked 
the following questions. (a) Is there a restricted TCR V~ 
repertoire in MS plaques?  (b) Is the TCR repertoire similar 
between plaques from the same case and between different 
cases of MS? (c) Is there a correlation between the TCR reper- 
toire in MS plaque tissue and the stage of the inflammatory 
process? (d) Which cytokine genes are expressed in MS plaques, 
and does cytokine gene expression correlate with the degree 
of inflammation and demyelination? The TCR V~-Va reper- 
toire was examined in a series of histologically well-defined 
plaques from six postmortem MS brains, samples from five 
cases without neurological disease, and one case of subacute 
sclerosing panencephalitis (SSPE). These samples represent 
stages of plaque development ranging from early, acute le- 
sions to chronic plaques, allowing the TCR repertoire to be 
correlated with the stage of the inflammatory process. 
993  J. Exp. Med,  ￿9  The Rockefeller University  Press ￿9 0022-100719210410993/10 $2.00 
Volume 175  April 1992  993-1002 Materiah  and  Methods 
Histology.  Tissue blocks  ("~1 cm  3)  were dissected  from the 
CNS of six clinically and neuropathologica[ly definite cases of MS, 
one case of subacute sclerosing  panencephalitis,  and five control 
cases without neurological disease (Table 1). The unfixed tissue 
blocks were placed in O. C. T. compound (Merck, Poole,  UK) 
on cork disks, snap-frozen in isopentane cooled on liquid nitrogen, 
and stored at  -70~  in sealed containers (7). From each block, 
cryostat sections (10/~m) were cut onto glass slides. Then, 20 con- 
secutive sections were placed in a sterile Eppendorf tube for RNA 
extraction. Sections cut before and after the sections taken for RNA 
extraction were stained with hematoxylin and eosin as well as oil 
red O  using standard methods. The extent of positive  oil red O 
staining was assessed under light microscopy by two independent 
observers. 
lmmunohistology.  Acetone-fixed  (4~  10  rain)  sections  on 
gelatin-coated slides were incubated with mouse mAbs directed 
against CD2,  CD4,  CD8 (Dako, High Wycombe, UK), Ib2R 
(CD25) (Becton Dickinson & Co., Mountain View, CA), Vic-YI 
(the cytoplasmic chain of HLA-DR) (a gift from Dr. W. Knapp, 
University of Vienna), TCR-B (BF1) (gift from Dr. Mike Brenner, 
Harvard Medical School, Boston, MA), and the myelin lipid galac- 
tocerebroside (7) to demonstrate myelin loss in plaques.  Sections 
were  then  immunoperoxidase  stained  (8)  using  a  biotinylated 
anti-mouse IgG antibody and an avidin-biotin complex (Vector 
Laboratories,  Inc., Burlingame, CA), with 0.05% (wt/vol) 3,3'- 
diaminobenzidine  tetrahydrochloride (Sigma  Chemical Co.,  St. 
Louis,  MO),  0.013%  (wt/vol) hydrogen peroxide,  and 0.04% 
(wt/vol) nickel (II) chloride hexahydrate (9, 10). The noncounter- 
stained sections were dehydrated and cleared in ethanol-xylene and 
mounted in D. P. X. mountant (BDH). Staining with these anti- 
bodies was graded by two independent observers (table 2). Tissue 
from one MS patient (case 481), who had had a rapidly progressive 
Table  1.  MS and Control Cases Examined 
disease course over 2 yr, was examined by hematoxylin and eosin 
staining but not by immtmohistology. This analysis demonstrated 
large numbers of actively demyelinating plaques in the cerebrum 
and cerebellum. 
RNA Extraction and cDNA Synthesis.  20 consecutive frozen sec- 
tions (10/~m) from each block were placed in a sterile Eppendorf 
tube for RNA extraction. RNA was extracted using the method 
of Chomczynski and Sacchi (11). To each tube, 1 ml of  cold RNAzol 
(Cinna Biotex Friends,  Wood, TX) was added and the tube vor- 
texed. After a 5-min incubation on ice, 100 ~al of chloroform was 
added,  and the samples were centrifuged for 15 min at 4~  The 
upper phase was then transferred to a clean tube containing an equal 
volume of isopropanol and 10/~g of tRNA as a carrier.  After a 
15-rain incubation on ice, the sample was again centrifuged at 4~ 
for 15 min, the superuatant aspirated off, and the RNA pellet washed 
with 1 ml of cold 70% ethanol. The air-dried pelht was resuspended 
in 10 ~1 of autoclaved distilled water and stored at - 70~  cDNAs 
were synthesized using AMV-reverse transcriptase  (Bethesda  Re- 
search Laboratories,  Rockville, MD), oligo-dT (Sigma Chemical 
Co.), and 5/~1 of RNA sample in 20-~1 reactions as described pre- 
viously (12). cDNA reactions were diluted with autochved dis- 
tilled water to 500/~I and stored at -70~  10/~l of  diluted cDNA 
was used for each PCR reaction, thus allowing 50 amplifications 
to be performed from each sample. 
PCR Amplification and Southern Blotting.  Samples  were amplified 
by PCR for 30 cycles (1 rain at 94~  2 min at 55~  3 min at 
72~  when  using  TCR  Vo,  TCR  V~,  TCR  C~,  and  actin 
primers, while 35 cycles were used for Ibl, IL-2, and IL,4 amplifica- 
tions. 1/~g of forward and 1 ~ag reverse primers (30 mers)  were 
added to 50-~1 reactions containing 5 ~1 of 10x taq buffer, dNTPs, 
and 2.5 U  of taq polymerase (Cetus Corp., EmeryviUe, CA) ac- 
cording to the manufacturer's  suggestions. Amplified products were 
Duration  Death-freezing 
Patients  Brain  Age  Sex  of disease  Pathology  time 
yr  h 
MS  285  35  M  8 mo  Acute plaques  throughout  spinal  28 
cord, rare lesions  in brain 
481  40  M  2 yr  Acute lesions  in brain  4 
(no autopsy on spinal  cord) 
194  26  M  3 yr  Acute plaques  throughout  18 
spinal  cord and brain 
214  43  M  6 yr  Acute and chronic lesions in  34 
brain and spinal  cord 
279  36  F  10 yr  Acute plaques  in spinal  cord,  33 
chronic periventricular lesions 
302  71  F  50 yr  Chronic plaques  in brain and  42 
upper spinal  cord 
Control  284  50  F  10 
289  43  M  2 
290  67  M  18 
292  42  M  21 
293  20  M  33 
994  T Cell Receptor V~,-VB Repertoire in Multiple Sclerosis resolved on 1%  agarose gels, denatured, neutralized, and trans- 
ferred  to  nitrocellulose membranes (Schleicher &  Schuell,  Inc., 
Keene, NH). Southern blots were hybridized with internal oligo- 
nucleotide probes hbeled with [3ZP]ATP  and T4-polynucleotide ki- 
nase. Hybridizations were done at 37~  for 18 h in 6 x  SSC, 5 x 
Table  2.  Imrau.ohistochemical and PCR Analysis of Plaque Tissue 
Denhardt's. 0.05% pyrophosphate.  100 ~g/ml of denatured her- 
ring sperm DNA, 0.5% SDS, and 106 cpm of labeled oligonucle- 
otide/ml of hybridization buffer. Blots were washed at a final strin- 
gency of6x  SSC at 70~  and processed for autoradiography (12). 
A number of precautions were applied to pre~nt accidental con- 
Oil red O 
Patients  Case  Location  Pathology  stain 
Immunohistology  PCR 
CD2  CD4  CD8  IL2R  la  IL-1  IL-2  IL-4 
MS  285 
Control 292 
I-6  Spinal cord  Early, acute plaque  + + 
I-7  Periventricular  White matter 
I-8  Corpus callosum Early, acute plaque  + 
I-9  Periventricular  White matter 
194  1-16 Spinal cord  Acute plaque  + + + + + 
1-17  Periventricular  Acute plaque  + + + + + 
1-18  Pons  Acute  plaque  + + + + 
1-19  Medulla  Acute plaque  + + + + 
1-20  Meninges  + 
279  II-2  Spinal cord  Subacute plaque  + + + 
II-3  Spinal cord  Subacute plaque  + + + 
II-5  Periventricular  Mixed plaques  + 
II-6  Corpus callosum Chronic plaque 
302  I1-8 Pedventricular  Chronic plaque 
II-9  Periventricular  Chronic plaque 
II-11 Pefiventricular  Chronic plaque 
II-12 Periventricular  Chronic plaque 
214  II-14 Spinal cord  Chronic plaque  - 
II-15 Cerebellum  Mixed  plaques  + 
I1-17 Periventricular  White matter 
II-18 Periventricular  White matter 
I-1  Spinal cord 
I-2  Periventricular 
I-3  Corpus caUosum 
I-4  Periventricular 
293  1-11 Spinal cord 
1-12  Periventricular 
1-13  Pons 
1-14  Subcortical 
1-15  Corpus callosum 
289  1I-1 Spinal cord 
II-4  Periventricular 
290  II-7  Periventricular 
II-10 Periventricular 
284  II-13 Periventricular 
II-16 Periventricular 
SSPE 
II-20 White matter  + + 
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++  +  ++  -  +  ND 
+  +  +  --  +  +  --  _ 
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+  +  +  -  +  ND 
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995  Wucberpfennig  et al. Figure  1.  (A-E) Cryostat sections of a perivenular inflammatory cuff and the surrounding tissue in a pons demyelinating plaque (sample 1-18). (A). 
Hematoxylin and eosin staining;  (B) oil red O  staining of degenerating myelin in microglia and macrophages. (C-E) immunoperoxidase staining of 
the same cuff;  (C) anti-CD2 antibody;  (D) anti-TCR/~ antibody (all  x165).  (E) Anti-TCR B antibody (x660);  (F) anti-TCR B immunostaining of 
a pons blood vessel in a normal control case (sample  1-13) (x165).  No hematoxylin counterstaining  of nuclei  in B-F. 
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(12). Working areas were separated for pre- and post-PCR experi- 
ments, and a set of  positive displacement  pipetteman was specifically 
designated  for RNA extractions and preparation of PCR reactions. 
All reagents were aliquoted and systematically  tested for possible 
contamination. Negative controls (no cDNAs) were included in 
experiments and MS samples run concurrently  with control samples. 
Results 
Examination of TCR Repertoire  from MS Plaques Using  RNA 
Extracted  from Frozen Sections.  The TCR V~-Va repertoire 
was examined in acute,  subacute, and chronic MS lesions, 
and control tissue that was characterized histologically for 
the degree of T  cell infiltration and demydination (Tables 
1 and 2).  Since unfixed, frozen tissue was only available in 
small quantities, RNA was extracted from thin frozen sec- 
tions, cDNAs synthesized from these RNA samples  were 
amplified by PCR using primers  for TCR Ca and actin. 
Actin could be amplified from all brain samples (except  I-7 
and II-8)  and gave an appropriately sized band on agarose 
gels that hybridized to an internal actin oligonucleotide probe 
on Southern blots. As expected, amplification of TCR Ca 
demonstrated that more TCR Ca mRNA was present in 
acute MS plaques than in chronic lesions and control samples, 
while the amount of actin mRNA amplified was similar (data 
not shown). Both actin and TCR Ca priming sites spanned 
an intron(s), allowing products amplified from cDNA and 
genomic DNA  to be distinguished by size. 
Histological and lramunocytochemical  Analysis of MS Plaque 
Tissue.  CNS tissue was examined histologically using oil 
red O, a marker for degenerating myelin, as well as hema- 
toxylin-eosin. Plaques with pefivenular inflammation, hyper- 
cellularity, and oil red O-positive degenerating myelin were 
considered to be acute, while hypocellular galactocerebroside- 
negative demydinated plaques were classified  as chronic. Acute 
plaques were further characterized  as early, acute, or subacute 
on the basis ofoil red O and galactocerebroside staining. Both 
acute and chronic lesions were present in some sections, which 
were classified as "mixed plaques" (Table 2). 
To characterize the T cell infiltrate in MS plaques and white 
matter samples, sections were stained with mAbs for CD2, 
CD4, CD8, Ib2K, and HLA-DR (Table 2). CD2 + T  cells 
were found in largest numbers around blood vessels in early 
acute and acute lesions, but were also present in subacute and 
chronic lesions (Fig. 1). Small numbers of T cells were found 
in  control  CNS  samples.  In  general,  more  CD8 §  than 
CD4 §  T  cells were present in acute and chronic plaques. 
Two of four samples from a patient with early disease (case 
285) were found to have the greatest numbers of  IL,2R-positive, 
activated T  cells (Table 2). 
Analysis of lnterleukin mRNA for IL-I, IL-2, and 11_,4  from 
Acute and Chronic Plaques.  mRNAs for Ibl, I1.2,  and II-4 
were examined in acute, subacute, and chronic lesions as well 
as white matter by PCR amplification and Southern blot- 
ting (Fig. 2). RNA extracted from a PMA ionomycin-acti- 
rated T cell clone was used as a positive control for all three 
primer pairs. Amplification of cDNA from this activated clone 
resulted in a strong band for II.-1, I1-2, and I1-4, while nega- 
tive controls (no cDNA) gave no signals  (Fig.  2).  I1-2 and 
Ib4 mRNA were detected in some acute and subacute le- 
sions.  In contrast, II.-1 mKNA was found in the majority 
of early acute, acute, and subacute plaques, but not in chronic 
lesions (Fig. 2). Lower levels of I1-1 mRNA were observed 
in some of the control samples. 
Figure 2.  Examination  of IL-1, Ib2, and Ib4 mRNAs in MS plaque tissue. Interleukin  cDNAs were amplified  by PCR for 35 cycles  and Southern 
blots hybridized  with internal oligonucleotide  probes, lbl could be amplified  from the majority  of early acute, acute, and subacute plaques, while 
lb2 and IIM were amplified  from a few acute and subacute lesions, lbl mRNA was also found at lower levels in some of the control brains and 
may be derived from microglia  or T cells. Controls (no cDNA) were negative  after amplification  with interleukin  primers, lbl, lb2, and II.,-4 could 
be efficiently  amplified  using  cDNA from a PMA/ionomycin-activated  T cell clone (positive  control). The integrity  of brain cDNAs was demonstrated 
using actin primers for amplification. 
997  Wucherpfennig  et al. Table  3.  Sequences of TCR, Interleukin, and Actin Pn'mers Used  for PCR Amplification 
TCR  V, primers 
V.1 
V.2 
V~3 
V.4 
V.5 
V.6 
V.7 
V.8 
V.9 
V.10 
V~ll 
V.12 
V.13 
V.14 
V~15 
V~16 
V~17 
V~18 
C~  primer 
C~ probe 
TCR  C~ primers 
TCR  Ca  Forward 
Reverse 
Probe 
Interleukin primers 
IL-lfl  Forward 
Reverse 
Probe 
IL-2  Forward 
Reverse 
Probe 
IL-4  Forward 
Reverse 
Probe 
Actin primers 
Actin  Forward 
Reverse 
Probe 
5' CTG CTG CTC  GTC  CCA GTG CTC  GAG GTG ATT 3' 
5' ACA GTG ACC GAG TTT  CCC  AGT CCT  TCT  TCT  3' 
5' GGA GTG TCT  TTG GTG  ATT CTA TGG CTT  CAA 3' 
5' CTC  CAC  AAT CAG TGG AAC TGA TTA  CAT ACA 3' 
5' AAC TAT ACA AAC TAT TCT  CCA  GCA TAC TT 3' 
5' CTG  AAG GTG GTC  ACA GCT TCA CTG  TGG CTA 3' 
5' TGG GGA GTT  TTC  CTT  CTT  TAT GTT  TCC  ATG Y 
5' CGA GCT TTA  TTT  ATG TAC TTG TGG CTG  CAG 3' 
5' CCC  ACC CTC  ATC TCA GTG CTT  GTG ATA ATA 3' 
5' ACC CAG CTG CTG GAG CAG AGC CCT  CAG TTT  3' 
5' GCT TTG CAG AGC ACT CTG  GGG GCG GTG TGG 3' 
5' TTG  AGG GCA GTC ATA GCC  TCC  ATC TGT GTT 3' 
5' GCT CTG  CTG  GGG CTC  TTG AGT GCC  CAG GTT 3' 
5' GCA TGC CCT  GGC TTC  CTG TGG GCA CTT  GTG 3' 
5' TGT TTC  CTT  GTT TAT GCT  GAG CTC  AGG GAA 3' 
5' ATC TCG  ATG CTT  GCG ATG CTC  TTC  ACA TTG 3' 
5' ATA TCT  ATA AGT TCC  ATT  AAG GAT AAA AAT 3' 
5' TGT CAG GCA ATG ACA AGG GAA GCA ACA AAG 3' 
5' TTG  TTG  CTC  CAG GCC  ACA GCA CTG TTG  CTC  3' 
5' CTT  GTC  ACT GGA TTT  AGA GTC  TCT  CAG CTG 3' 
5' CCC  GAG GTC  GCT  GTG TTT  GAG CCA TCA  GAA Y 
5' GGC  AGA CAG GAC CCC  TTG CTG GTA GGA CAC 3' 
5' TGT GCA CCT  CCT  TCC  CAT TCA CCC  ACC AGC 3' 
5' GAC AAG CTG  AGG 
5' TCT  TTC  AAC ACG 
5' GAT ATG GAG CAA 
5' TAC  AGG ATG CAA 
5' GTT GCT GTC  TCA 
5' CAG TGT CTA GAA 
5' CTG CTA GCA TGT 
5' GAA GTT TTC  CAA 
5' GAG CAG AAG ACT 
AAG ATG CTG  GTT CCC  TGC  3' 
CAG GAC AGG TAC AGA TTC  3' 
CAA GTG GTG TTC  TCC  ATG 3' 
CTC  CTG  TCT  TGC  ATT GCA 3' 
TCA GCA TAT  TCA CAC ATG 3' 
GAA GAA GAA CTC  AAA CCT  CTG 3' 
GCC  GGC AAC TTT  GTC  CAC 3' 
CGT  ACT CTG  GTT  GGC TTC  3' 
CTG TGC  ACC GAG TTG  ACC 3' 
5' AAC CCC  AAG GCC  AAC CGC  GAG AAG ATG ACC Y 
5' GGT GAT GAC CTG  C-CC  GTC  AGG CAG CTC  GTA 3' 
5' GCC  CTG GAC TTC  GAG CAA GAG ATG GCC  ACG 3' 
998  T Cell Receptor V,,-Vt~ Repertoire in Multiple Sclerosis TCR  V~-VB Repertoire in MS Plaque Tissue Is Polyrlonal. 
We then examined the TCR V,~-Vt~  repertoire in MS inflam- 
matory lesions by PCR using a panel of TCR V0 primers 
(12). We also assembled a new panel of TCR V~ primers 
(V,,1-V,,18) (Table 3).  All of these primers  efficiently am- 
plified V,,1-V,,18 gene segments  using cDNA synthesized 
from PBL. TCR V,, primers were tested on a set of 11 T 
cell dones established  from peripheral  blood of  a normal subject 
by single-cell cloning using PHA and IL-2. All clones studied 
were found to have a single TCR V0 rearrangement and one 
or two TCR V,, rearrangements  (data not shown). 
cDNAs from MS plaque and control samples  were amplified 
by PCR for 30 cycles using V,,1-V,,18 primers,  as well as 
V01-V019 primers in combination with a C~ or a Ca primer, 
respectively (Fig. 3, a and b). Actin amplification was used 
as a positive control to demonstrate that samples contained 
similar amounts of cDNA. Southern blots were hybridized 
with internal oligonucleotide  probes for C,,, Ca, and actin 
in order to demonstrate the specificity of amplification. The 
majority of samples contained functional cDNA (except I-7 
and II-8). Despite variable postmortem times, most samples 
gave similar signals after amplification with actin primers. 
Actin amplification from brain samples 214 and 289 (chronic 
MS and control brain, respectively) gave lower signals than 
amplification from other samples (Fig. 2). 
Using this approach, a large number of different V~ and 
V0 segments were detected in acute MS plaque samples. The 
following V,, and Va gene segments were present in most 
acute and subacute specimens: V,~2, V,~3, V~8, V~12, V,~14, 
and V,~17; V01, V02, Vo4, V05, V07, V08, Vt~12, V014, 
Vt~16, and Vtfl7. A polyclonal TCR Va gene repertoire was 
also found in the white matter of a case of SSPE (Fig. 3 a). 
Large numbers of CD2- and IL-2-positive T cells were de- 
tected in this white matter sample; there was also evidence 
of  ongoing demyelination as oil red O staining revealed  phago- 
cytosed myelin in macrophages (Table 2). In chronic MS and 
control samples, fewer TCR V-gene segments were detected, 
probably due to the small number of T cells and the minute 
quantities  of TCR mRNA present(Fig. 3, a and b). 
TCR  VcVB Repertoire Shows l~'fferences between Lesions 
from the Same Case  For each MS case examined, the TCR 
repertoire was analyzed for three to five plaques to determine 
if the same repertoire would be present among different le- 
sions. Although most of the TCR V,, and Ve gene seg- 
ments amplified  were similar, dear differences  between plaques 
obtained  from the same MS case were observed (Fig. 4). 
Discussion 
The  TCR  V~-V~ repertoire  and  ILl,  Ib2,  and  II.-4 
mRNA were examined in CNS tissue from cases of MS and 
compared with plaque pathology. A polyclonal TCR V~-Va 
repertoire was present in acute lesions while fewer V gene 
segments  were detected  in  chronic and  control  samples. 
Among different plaques from the same case, most of the 
TCR V,, and Vt3 gene segments amplified were similar, al- 
though clear differences between plaques were observed. Ex- 
amination of  cytokine mRNAs demonstrated that ILl mRNA 
was present in the majority of acute and subacute plaques, 
while IL-2 and Ib4 mRNA were detected in only a few acute 
lesions. These data indicate that the TCR repertoire in MS 
plaques is polyclonal. 
Since MS may be a T cell-mediated autoimmune disease, 
the analysis of the T cell repertoire involved in the inflamma- 
tory process is of importance. In particular, characterization 
of the TCR repertoire in the target organ could be a direct 
way to examine T cells important in the pathogenesis of MS. 
Such an analysis is unfortunately  complicated by the fact that 
large numbers of antigen-nonspecific T cells are recruited to 
inflammatory lesions. For example, in experimental autoim- 
mune encephalomyelitis (EAE) induced by injection of my- 
elin basic protein (MBP), the frequency of MBP-specific T 
cells in the blood and in the brain is very low (13). However, 
a recent study had suggested that a restricted TCR V,~ reper- 
toire is present in MS plaques, although no pathological in- 
formation was provided (6). This is a common di~culty be- 
cause CNS specimens from MS patients that are adequately 
frozen for histological analysis can be only obtained in small 
quantities.  For those reasons, we performed a study on the 
TCR V,~-Va repertoire  using samples that were histologi- 
cally well characterized and extracted RNA from thin frozen 
sections. Our analysis demonstrates that a polyclonal TCR 
V,~-V0 repertoire is present in active lesions. This is not sur- 
prising since the breakdown of the blood-brain barrier in acute 
lesions is likely to lead to recruitment of large numbers of 
T cells, of which the minority is specific for the target an- 
tigen initiating the disease, as observed in EAE (13). Fewer 
TCR V gene segments were amplified from chronic lesions 
and control samples, probably due to the minute quantities 
of TCR mRNA present. Since antigen-specific T cells prob- 
ably represent a small minority in MS plaques, we recently 
examined TCR V0 gene usage among peripheral blood T 
cells specific  for an immunodominant region of MBP (residues 
84-102). This analysis  demonstrated that there was a preferen- 
tial TCR usage in recognition of immunodominant MBP 
peptides (12). For these reasons, an analysis of the TCR reper- 
toire of antigen-specific T cells cultured directly from acute 
MS plaques would be of great interest. 
A comparison of the TCR V,~-V0 repertoire from different 
plaques of the same MS case as well as different cases demon- 
strated  that  a  number of V,~ and  V0 gene segments  are 
present in most of the active lesions. These V,~ and V0 gene 
segments include V,~2, V,~3, V,~8, V,~12, V,~14, and V~17; 
V01, Va2, V~,  VBS, V~7, V08, V~12, V014, V016, and 
V017. Nevertheless, there were clear differences in the TCR 
repertoire between plaques from the same case, similar to what 
has been shown previously (6). This suggests that local events 
in MS plaques influence the TCR repertoire at the level of 
T  cell recruitments or T  cell expansion. 
In summary, our data demonstrate that the TCR reper- 
toire in MS inflammatory lesions is polyclonal. As antigen- 
specific T cells that may be critical for the initiation of an 
inflammatory lesion are probably in the minority, autoreac- 
tive T cells involved in the disease process may nevertheless 
have a limited TCR V gene repertoire. 
999  Wucherpfennig  et al. 1000  T  Cell Receptor V~-V  a Repertoire in Multiple Sclerosis Figure 3.  PCR analysis of TCR V~ and Vt~ repertoire in MS plaque 
tissue, cDNA synthesized from MS plaque RNA was amplified  using TCR 
Va (V~1-19) (a) and TCR V,~ (V,~1-18) primers (b). Southern blots are 
shown for active MS plaques (A) and chronic MS lesions (B), control CNS 
samples (C),  and white matter of a case with SSPE (D).  Amplification 
of actin cDNA was used as a positive control. This analysis demonstrates 
that a polyclonal TCR repertoire is present in acute lesions. Control ex- 
periments  (no cDNA) gave no amplification of TCR gene segments. 
1001  Wucherpfennig et al. Figure 4.  Plaque-to-plaque  diversity  of the TCIL  V~ and V~ repertoire. A PCR analysis of TCR V,~ (V~1-18), TCR V~ (V~1-19) gene segments, 
and of actin cDNA is shown for CNS samples from three MS cases to allow comparison  of the TCR repertoire  between plaques from each case. Clear 
differences in the TCR V~ and V~ repertoire  is seen between plaques, indicating that local events in the CNS influence the TCR repertoire. 
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